Krka d. d (KRK) - Total Assets
Based on the latest financial reports, Krka d. d (KRK) holds total assets worth zł3.34 Billion PLN (≈ $918.05 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Krka d. d - Total Assets Trend (2010–2025)
This chart illustrates how Krka d. d's total assets have evolved over time, based on quarterly financial data. Also see Krka d. d (KRK) total market value for the company's overall valuation and market capitalisation.
Krka d. d - Asset Composition Analysis
Current Asset Composition (December 2025)
Krka d. d's total assets of zł3.34 Billion consist of 65.2% current assets and 34.8% non-current assets. Review Krka d. d (KRK) financial obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (PLN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 11.4% |
| Accounts Receivable | zł734.05 Million | 24.1% |
| Inventory | zł644.42 Million | 21.2% |
| Property, Plant & Equipment | zł0.00 | 0.0% |
| Intangible Assets | zł57.14 Million | 1.9% |
| Goodwill | zł42.64 Million | 1.4% |
Asset Composition Trend (2010–2025)
This chart illustrates how Krka d. d's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Krka d. d stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Krka d. d's current assets represent 65.2% of total assets in 2025, an increase from 43.1% in 2010.
- Cash Position: Cash and equivalents constituted 11.4% of total assets in 2025, up from 0.5% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 27.0% in 2010.
- Asset Diversification: The largest asset category is accounts receivable at 24.1% of total assets.
Krka d. d Competitors by Total Assets
Key competitors of Krka d. d based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Beijing Tongrentang Co Ltd
SHG:600085
|
China | CN¥31.82 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Neuland Laboratories Limited
NSE:NEULANDLAB
|
India | Rs29.30 Billion |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
|
China | CN¥17.01 Billion |
Krka d. d - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.21 | 4.42 | 4.24 |
| Quick Ratio | 3.03 | 3.13 | 2.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | zł1.71 Billion | zł1.62 Billion | zł1.04 Billion |
Krka d. d - Advanced Valuation Insights
This section examines the relationship between Krka d. d's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.03 |
| Latest Market Cap to Assets Ratio | 3.10 |
| Asset Growth Rate (YoY) | 6.8% |
| Total Assets | zł3.04 Billion |
| Market Capitalization | $9.43 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Krka d. d's assets at a significant premium (3.10x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Krka d. d's assets grew by 6.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Krka d. d (2010–2025)
The table below shows the annual total assets of Krka d. d from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | zł3.04 Billion ≈ $837.79 Million |
+6.85% |
| 2024-12-31 | zł2.85 Billion ≈ $784.09 Million |
+3.07% |
| 2023-12-31 | zł2.76 Billion ≈ $760.77 Million |
+2.86% |
| 2022-12-31 | zł2.69 Billion ≈ $739.64 Million |
+5.90% |
| 2021-12-31 | zł2.54 Billion ≈ $698.41 Million |
+13.52% |
| 2020-12-31 | zł2.24 Billion ≈ $615.25 Million |
+2.33% |
| 2019-12-31 | zł2.18 Billion ≈ $601.24 Million |
+10.05% |
| 2018-12-31 | zł1.99 Billion ≈ $546.32 Million |
+3.44% |
| 2017-12-31 | zł1.92 Billion ≈ $528.17 Million |
+0.40% |
| 2016-12-31 | zł1.91 Billion ≈ $526.08 Million |
+5.66% |
| 2015-12-31 | zł1.81 Billion ≈ $497.92 Million |
+0.75% |
| 2014-12-31 | zł1.80 Billion ≈ $494.21 Million |
+2.04% |
| 2013-12-31 | zł1.76 Billion ≈ $484.35 Million |
+8.18% |
| 2012-12-31 | zł1.63 Billion ≈ $447.70 Million |
+6.04% |
| 2011-12-31 | zł1.53 Billion ≈ $422.19 Million |
+3.08% |
| 2010-12-31 | zł1.49 Billion ≈ $409.58 Million |
-- |
About Krka d. d
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, an… Read more